All Stories

  1. A snapshot of the ongoing clinical research on COVID-19

    Article • F1000Research, May 2020, Faculty of 1000, Ltd.

    Dr Dimitrios Paraskevis, Daniele Piovani

  2. A hepatitis C outbreak preceded the HIV outbreak among persons who inject drugs in Athens, Greece: Insights from a mathematical modelling study

    Article • Journal of Viral Hepatitis, August 2019, Wiley

    Dr Dimitrios Paraskevis

  3. Identifying, linking, and treating people who inject drugs and were recently infected with HIV in the context of a network-based intervention

    Article • AIDS Care, April 2019, Taylor & Francis

    Dr Dimitrios Paraskevis, Dr Georgios Nikolopoulos, GIORGOS GIALLOUROS, Andria Hadjikou, ANASTASIA ANTONIADOU

  4. Near Full-length Genomic Sequencing and Molecular Analysis of HIVInfected Individuals in a Network-based Intervention (TRIP) in Athens, Greece: Evidence that Transmissions Occur More Frequently from those with High HIV-RNA

    Article • Current HIV Research, March 2019, Bentham Science Publishers

    Dr Georgios Nikolopoulos, Dr Dimitrios Paraskevis, Jade Raffle, Andria Hadjikou

  5. Platelet and coagulation disorders in newly diagnosed patients with pulmonary arterial hypertension

    Article • Platelets, July 2018, Taylor & Francis

    Dr Dimitrios Paraskevis, Petros kopterides, Professor Apostolos Armaganidis, Eleni Vrigkou

  6. Detailed Molecular Surveillance of the HIV-1 Outbreak Among People who Inject Drugs (PWID) in Athens During a Period of Four Years

    Article • Current HIV Research, January 2018, Bentham Science Publishers

    Dr Dimitrios Paraskevis, Dr George L Daikos, Eleni Papachristou

  7. Pre-Exposure Prophylaxis for HIV: Evidence and Perspectives

    Article • Current Pharmaceutical Design, July 2017, Bentham Science Publishers

    Dr Dimitrios Paraskevis

  8. Hyperbilirubinemia in atazanavir treated HIV-infected patients: the impact of the UGT1A1*28 allele

    Article • Pharmacogenomics and Personalized Medicine, June 2017, Dove Medical Press

    Dr Dimitrios Paraskevis

  9. Recent HIV-1 Outbreak Among Intravenous Drug Users in Romania: Evidence for Cocirculation of CRF14_BG and Subtype F1 Strains

    Article • AIDS Research and Human Retroviruses, May 2015, Mary Ann Liebert Inc

    Dr Dimitrios Paraskevis

  10. Molecular characterization of HIV-1 infection in Northwest Spain (2009–2013): Investigation of the subtype F outbreak

    Article • Infection Genetics and Evolution, March 2015, Elsevier

    Dr Dimitrios Paraskevis

  11. Homelessness and Other Risk Factors for HIV Infection in the Current Outbreak Among Injection Drug Users in Athens, Greece

    Article • American Journal of Public Health, January 2015, American Public Health Association

    Dr Dimitrios Paraskevis

  12. Species Based Synonymous Codon Usage in Fusion Protein Gene of Newcastle Disease Virus

    Article • PLoS ONE, December 2014, PLOS

    Dr Dimitrios Paraskevis

  13. Persistence of frequently transmitted drug-resistant HIV-1 variants can be explained by high viral replication capacity

    Article • Retrovirology, November 2014, Springer Science + Business Media

    Dr Dimitrios Paraskevis

  14. Patterns of drug resistance among newly diagnosed HIV-1 infected patients in Greece during the last decade: the crucial role of transmission networks

    Article • Journal of the International AIDS Society, November 2014, Wiley

    Dr Dimitrios Paraskevis

  15. Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe

    Article • BMC Infectious Diseases, July 2014, Springer Science + Business Media

    Dr Dimitrios Paraskevis

  16. Patterns of Transmitted HIV Drug Resistance in Europe Vary by Risk Group

    Article • PLoS ONE, April 2014, PLOS

    Dr Dimitrios Paraskevis

  17. HIV-1 epidemic in Russia: an evolutionary epidemiology analysis

    Article • The Lancet, February 2014, Elsevier

    Dr Dimitrios Paraskevis

  18. Economic Recession and Emergence of an HIV-1 Outbreak among Drug Injectors in Athens Metropolitan Area: A Longitudinal Study

    Article • PLoS ONE, November 2013, PLOS

    Dr Dimitrios Paraskevis

  19. Socially-Integrated Transdisciplinary HIV Prevention

    Article • AIDS and Behavior, October 2013, Springer Science + Business Media

    Dr Dimitrios Paraskevis

  20. Ultrasensitive assay for detection of minority HBV resistance mutations

    Article • Journal of Clinical Microbiology, June 2013, ASM Journals

    Dr Dimitrios Paraskevis

  21. Detailed Molecular Epidemiologic Characterization of HIV-1 Infection in Bulgaria Reveals Broad Diversity and Evolving Phylodynamics

    Article • PLoS ONE, March 2013, PLOS

    Dr Dimitrios Paraskevis

  22. Dating the origin and dispersal of hepatitis B virus infection in humans and primates

    Article • Hepatology, February 2013, Wolters Kluwer Health

    Dr Emmanouil Magiorkinis, Dr Dimitrios Paraskevis

  23. Integrating Phylodynamics and Epidemiology to Estimate Transmission Diversity in Viral Epidemics

    Article • PLoS Computational Biology, January 2013, PLOS

    Dr Emmanouil Magiorkinis, Dr Dimitrios Paraskevis

  24. Subgenotype A1 of HBV – tracing human migrations in and out of Africa

    Article • Antiviral Therapy, January 2013, International Medical Press

    Dr Dimitrios Paraskevis

  25. Limited cross-border infections in patients newly diagnosed with HIV in Europe

    Article • Retrovirology, January 2013, Springer Science + Business Media

    Dr Dimitrios Paraskevis

  26. Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients

    Article • Retrovirology, October 2012, Springer Science + Business Media

    Dr Dimitrios Paraskevis, Dr. Vicente Soriano

  27. Molecular typing of the recently expanding subtype B HIV-1 epidemic in Romania: Evidence for local spread among MSMs in Bucharest area

    Article • Infection Genetics and Evolution, July 2012, Elsevier

    Dr Dimitrios Paraskevis

  28. Assessment of phylogenetic sensitivity for reconstructing HIV-1 epidemiological relationships

    Article • Virus Research, June 2012, Elsevier

    Dr Emmanouil Magiorkinis, Dr Dimitrios Paraskevis

  29. Appearance of a Single Amino Acid Insertion at Position 33 in HIV Type 1 Protease Under a Lopinavir-Containing Regimen, Associated with Reduced Protease Inhibitor Susceptibility

    Article • AIDS Research and Human Retroviruses, November 2011, Mary Ann Liebert Inc

    Dr Emmanouil Magiorkinis, Dr Dimitrios Paraskevis

  30. HBV viremia in newborns of HBsAg(+) predominantly Caucasian HBeAg(−) mothers

    Article • Journal of Clinical Virology, March 2011, Elsevier

    Dr Dimitrios Paraskevis

  31. HIV Transmission Patterns Among The Netherlands, Suriname, and The Netherlands Antilles: A Molecular Epidemiological Study

    Article • AIDS Research and Human Retroviruses, February 2011, Mary Ann Liebert Inc

    Dr Dimitrios Paraskevis

  32. Comparative evaluation of the performance of the Abbott RealTime HIV-1 assay for measurement of HIV-1 plasma viral load on genetically diverse samples from Greece

    Article • Virology Journal, January 2011, Springer Science + Business Media

    Dr Dimitrios Paraskevis

  33. Cellular HIV-1 DNA Levels in Drug Sensitive Strains Are Equivalent to Those in Drug Resistant Strains in Newly-Diagnosed Patients in Europe

    Article • PLoS ONE, June 2010, PLOS

    Dr Dimitrios Paraskevis

  34. Development of a new ultra sensitive real-time PCR assay (ultra sensitive RTQ-PCR) for the quantification of HBV-DNA

    Article • Virology Journal, March 2010, Springer Science + Business Media

    Dr Dimitrios Paraskevis

  35. The Global Spread of Hepatitis C Virus 1a and 1b: A Phylodynamic and Phylogeographic Analysis

    Article • PLoS Medicine, December 2009, PLOS

    Dr Emmanouil Magiorkinis, Dr Dimitrios Paraskevis

  36. Prevalence of different HPV types and estimation of prognostic risk factors based on the linear array HPV genotyping test

    Article • Journal of Medical Virology, December 2009, Wiley

    Dr Dimitrios Paraskevis

  37. Transmission of Drug‐Resistant HIV‐1 Is Stabilizing in Europe

    Article • The Journal of Infectious Diseases, November 2009, Oxford University Press (OUP)

    Dr Dimitrios Paraskevis

  38. Monitoring HIV drug resistance in treatment-naive individuals: molecular indicators, epidemiology and clinical implications

    Article • HIV Therapy, July 2009, Future Medicine

    Dr Emmanouil Magiorkinis, Dr Dimitrios Paraskevis

  39. Impact of Hepatitis B Virus Infection on the Progression of AIDS and Mortality in HIV‐Infected Individuals: A Cohort Study and Meta‐Analysis

    Article • Clinical Infectious Diseases, June 2009, Oxford University Press (OUP)

    Dr Dimitrios Paraskevis

  40. Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach

    Article • Retrovirology, May 2009, Springer Science + Business Media

    Dr Dimitrios Paraskevis, Dr. Vicente Soriano

  41. The Role of HIV-1 DNA as an Additional Marker of HIV-1 Infection

    Article • Current HIV Research, May 2009, Bentham Science Publishers

    Dr Dimitrios Paraskevis

  42. Molecular characterization of occult hepatitis B cases in Greek blood donors

    Article • Journal of Medical Virology, March 2009, Wiley

    Dr Emmanouil Magiorkinis, Dr Dimitrios Paraskevis

  43. HIV epidemiology in Greece

    Article • Future Microbiology, October 2008, Future Medicine

    Dr Dimitrios Paraskevis

  44. Comments on “The distribution of HIV-1 recombination breakpoints” by Jun Fan, Matteo Negroni, David L. Robertson

    Article • Infection Genetics and Evolution, September 2008, Elsevier

    Dr Dimitrios Paraskevis

  45. Role of genetic polymorphisms in the progression of liver fibrosis in chronic hepatitis C virus infection

    Article • Liver International, June 2008, Wiley

    Dr Dimitrios Paraskevis

  46. Emergence of an NNRTI Resistance Mutation Y181C in an HIV-Infected NNRTI-Naive Patient

    Article • AIDS Research and Human Retroviruses, March 2008, Mary Ann Liebert Inc

    Dr Emmanouil Magiorkinis, Dr Dimitrios Paraskevis

  47. Increasing Prevalence of HIV‐1 Subtype A in Greece: Estimating Epidemic History and Origin

    Article • The Journal of Infectious Diseases, October 2007, Oxford University Press (OUP)

    Dr Emmanouil Magiorkinis, Dr Dimitrios Paraskevis

  48. Short Communication: Dynamics of Drug-Resistant HIV-1 in Plasma and Peripheral Blood Cells in Patients during and after Enfuvirtide Therapy

    Article • AIDS Research and Human Retroviruses, September 2007, Mary Ann Liebert Inc

    Dr Dimitrios Paraskevis, Dr. Vicente Soriano

  49. Analysing the evolutionary history of HCV: Puzzle of ancient phylogenetic discordance

    Article • Infection Genetics and Evolution, June 2007, Elsevier

    Dr Emmanouil Magiorkinis, Dr Dimitrios Paraskevis

  50. 409 dating the HCV3a epidemic in greece using molecular clock approaches

    Article • Journal of Hepatology, April 2006, Elsevier

    Dr Emmanouil Magiorkinis, Dr Dimitrios Paraskevis

  51. Re-analysis of 34 full-length HIV-1 intersubtype recombinant sequences

    Article • Infection Genetics and Evolution, April 2005, Elsevier

    Dr Emmanouil Magiorkinis, Dr Dimitrios Paraskevis

  52. Re-analysis of a human hepatitis B virus (HBV) isolate from an East African wild born Pan troglodytes schweinfurthii: Evidence for interspecies recombination between HBV infecting chimpanzee and human

    Article • Gene, April 2005, Elsevier

    Dr Emmanouil Magiorkinis, Dr Dimitrios Paraskevis

  53. Analysis of complex HIV-1 intersubtype recombinants using a Bayesian scanning method

    Article • Infection Genetics and Evolution, April 2005, Elsevier

    Dr Dimitrios Paraskevis

  54. Web Service-Enabled Grid-Based Platform for Drug Resistance Management

    Article • January 2005, Springer Science + Business Media

    Dr Dimitrios Paraskevis

  55. SlidingBayes: exploring recombination using a sliding window approach based on Bayesian phylogenetic inference

    Article • Bioinformatics, November 2004, Oxford University Press (OUP)

    Dr Dimitrios Paraskevis

  56. Phylogenetic Reconstruction of a Known HIV-1 CRF04_cpx Transmission Network Using Maximum Likelihood and Bayesian Methods

    Article • Journal of Molecular Evolution, November 2004, Springer Science + Business Media

    Dr Emmanouil Magiorkinis, Dr Dimitrios Paraskevis

  57. Clinical evaluation of an HIV-1 and HCV assay and demonstration of significant reduction of the HCV detection window before seroconversion

    Article • Transfusion, January 2004, Wiley

    Dr Dimitrios Paraskevis

  58. Analysis of the Evolutionary Relationships of HIV-1 and SIVcpz Sequences Using Bayesian Inference: Implications for the Origin of HIV-1

    Article • Molecular Biology and Evolution, August 2003, Oxford University Press (OUP)

    Dr Dimitrios Paraskevis

  59. High prevalence of CRF02_AG and many minor resistance-related mutations at the protease gene among HIV-infected treatment-naive immigrants in Madrid

    Article • AIDS, May 2003, Wolters Kluwer Health

    Dr Dimitrios Paraskevis

  60. Genetic Evolution of Human Immunodeficiency Virus Type 1 in Two Spouses Responding Successfully to Highly Active Antiretroviral Therapy

    Article • AIDS Research and Human Retroviruses, January 2003, Mary Ann Liebert Inc

    Dr Dimitrios Paraskevis

  61. A viral kinetic study using pegylated interferon alpha 2b and lamivudine in naive patients with HBeAg(−)/I-BV-DNA(+) chronic hepatitis B: preliminary results

    Article • Journal of Hepatology, April 2002, Elsevier

    Dr Dimitrios Paraskevis

  62. Development of a novel real-time PCR assay for the quantitation of HBV DNA

    Article • Journal of Hepatology, April 2001, Elsevier

    Dr Dimitrios Paraskevis

  63. Development of a novel real-time PCR assay for the quantitation of HBV DNA

    Article • Journal of Hepatology, April 2001, Elsevier

    Dr Dimitrios Paraskevis

  64. Prevalence and genotypic distribution of TT virus in Athens, Greece

    Article • Journal of Medical Virology, January 2001, Wiley

    Dr Dimitrios Paraskevis

  65. Comparative evaluation of the QUANTIPLEX HIV-1 RNA 2.0 and 3.0 (bDNA) assays and the AMPLICOR HIV-1 MONITOR v1.5 test for the quantitation of human immunodeficiency virus type 1 RNA in plasma

    Article • Journal of Virological Methods, January 2001, Elsevier

    Dr Dimitrios Paraskevis

  66. Molecular epidemiology of GB virus C/hepatitis G virus in Athens, Greece

    Article • Journal of Medical Virology, January 2000, Wiley

    Dr Dimitrios Paraskevis

  67. Identification of reverse transcriptase mutations associated with HIV-1 drug resistance mainly against non-nucleoside reverse transcriptase inhibitors in treatment-naive patients

    Article • AIDS, July 1999, Wolters Kluwer Health

    Dr Emmanouil Magiorkinis, Dr Dimitrios Paraskevis

  68. Prevalence patterns and genotypes of GB Virus C/hepatitis G virus among imprisoned intravenous drug users

    Article • Journal of Medical Virology, November 1998, Wiley

    Dr Dimitrios Paraskevis

  69. Prevalence patterns and genotypes of GB Virus C/hepatitis G virus among imprisoned intravenous drug users

    Article • Journal of Medical Virology, November 1998, Wiley

    Dr Dimitrios Paraskevis

  70. Genotypic Characterization of Human Immunodeficiency Virus Type 1 in Greece

    Article • AIDS Research and Human Retroviruses, May 1998, Mary Ann Liebert Inc

    Dr Dimitrios Paraskevis

  71. The global spread of Hepatitis C Virus

    Article • SciVee, Inc

    Dr Emmanouil Magiorkinis, Dr Dimitrios Paraskevis

  72. The Global Dynamics and Spread of Hepatitis C Virus 1a and 1b: A Phylogeographical Analysis

    Article • SciVee, Inc

    Dr Emmanouil Magiorkinis, Dr Dimitrios Paraskevis